ÂÜÀòÂÒÂ×

Ms. Hou is a Managing Director at Montreux Growth Partners and an experienced healthcare investor.

Ms. Hou is actively involved with a number of Montreux’s investments in growth-stage companies. She currently serves on the board of Colorescience and as a board observer at FinPay, Crown Laboratories, and TigerConnect. She previously represented Montreux on the board of SI-BONE (NASDAQ: SIBN) and KFx Medical. She also managed Montreux’s investment in Tobira Therapeutics (NASDAQ: TBRA, acquired by Allergan).

Previously, she was at Quaker Partners, a healthcare investment firm, where she evaluated and executed investments in biopharmaceutical, medical device, diagnostics, healthcare services, and consumer healthcare companies. Prior to joining Quaker, Ms. Hou was a Managing Consultant at Navigant Consulting, where she led and conducted numerous projects in commercial strategy and business development advisory for healthcare clients, including large-cap and specialty pharmaceutical, biotechnology, and healthcare services companies. Ms. Hou also worked in marketing at Abbott on the global launch of its bioresorbable stent. She has contributed to policy and research initiatives supporting regulatory reform with the Medical Innovation and Competitiveness (MedIC) Coalition and National Venture Capital Association (NVCA).

Ms. Hou earned an M.B.A. from Stanford Graduate